More than 80% of the dogs' positive findings are in the general hospital environment.
Health officials in the Democratic Republic of the Congo (DRC) confirmed 6 more Ebola infections, raising the overall outbreak total to 3,049, according to the World Health Organization (WHO) online dashboard today. Also, outbreak responders are still investigating 327 suspected cases.
Ten more people died from their infections, raising the fatality count to 2,045.
CARB-X today announced an award of more than $1.6 million to biopharmaceutical company SutroVax of Foster City, Calif., to develop a vaccine to prevent infections caused by Group A Streptococcus.
Genomic analysis suggests C difficile strains that have spread in hospitals belong to an emerging species.
A population-based analysis indicates that hospital-acquired Clostridioides difficile infection (HA-CDI) is associated with millions of dollars in attributable costs and with extended hospital stays, Canadian researchers reported today in Infection Control and Hospital Epidemiology.
The Nebraska Department of Health and Human Services (NDHHS) yesterday issued a health alert about an increase in carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) cases this year. After detecting 7 each year in 2017 and 2018, officials have already confirmed 12 CP-CRE infections so far this year.
Researchers in Denmark report that the use of fecal microbiota transplantation (FMT) reduced hospital costs in patients with recurrent Clostridioides difficile infection (rCDI) by 42%, according to a study in Therapeutic Advances in Gastroenterology.
The Maryland State Senate and House of Delegates yesterday passed bills to strengthen a state law that restricts the routine use of antibiotics in animals that aren't sick.
The drug cut the incidence of C difficile by 2.4 percentage points—a 71% relative risk reduction.
Researchers with the US Centers for Disease Control and Prevention (CDC) reported today in Clinical Infectious Diseases that reductions in antibiotic use, particularly fluoroquinolones and third- and fourth-generation cephalosporins, was associated with a decrease in Clostridioides difficile rates in US acute care hospitals.
